ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$NBIX:NASDAQ · NEUROCRINE BIOSCIENCES INC

Conviction from: NASDAQ

Neurocrine Biosciences develops and commercializes therapies for neurological, neuroendocrine, and psychiatric disorders, including its lead product Ingrezza for tardive dyskinesia.

Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.

from2028 — cross-site stock view. Rebuilt at publish time.